SecSonar.com

CytoMed Therapeutics Limited (GDTC)

CytoMed Therapeutics Limited at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

CytoMed Therapeutics Limited (GDTC) is a Biotechnology company based in SG with a market capitalization of $13.4M. Revenue grew 513.8% year-over-year and free cash flow was negative at -$4.4M. This page tracks GDTC's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

SG · 43 employees · IPO Apr 14, 2023

Valuation

Valuation & price

$1.16 · as of May 26, 2026 · -56.9% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

—

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$2.57$1.67$0.77Jul 25Dec 25Jul 26Jul 7, 25$2.17Jul 9, 25$2.25Jul 11, 25$2.21Jul 15, 25$2.04Jul 17, 25$2.03Jul 21, 25$2.00Jul 23, 25$1.89Jul 25, 25$1.87Jul 29, 25$1.94Jul 31, 25$1.88Aug 4, 25$1.86Aug 6, 25$1.84Aug 11, 25$1.80Aug 13, 25$1.75Aug 15, 25$1.80Aug 19, 25$1.75Aug 21, 25$1.78Aug 25, 25$1.97Aug 27, 25$2.01Aug 29, 25$2.00Sep 3, 25$1.95Sep 5, 25$1.93Sep 9, 25$1.95Sep 11, 25$2.01Sep 16, 25$1.93Sep 18, 25$1.88Sep 22, 25$1.93Sep 24, 25$2.03Sep 26, 25$1.99Sep 30, 25$1.99Oct 2, 25$2.01Oct 6, 25$2.11Oct 8, 25$2.17Oct 10, 25$2.06Oct 14, 25$2.25Oct 16, 25$2.25Oct 21, 25$2.57Oct 23, 25$2.43Oct 27, 25$2.42Oct 29, 25$2.18Oct 31, 25$2.20Nov 4, 25$1.99Nov 6, 25$2.04Nov 10, 25$1.97Nov 12, 25$1.93Nov 14, 25$1.96Nov 18, 25$1.97Nov 20, 25$1.80Nov 25, 25$1.90Nov 28, 25$1.84Dec 2, 25$1.74Dec 4, 25$1.85Dec 8, 25$1.85Dec 10, 25$1.56Dec 12, 25$1.66Dec 16, 25$1.62Dec 18, 25$1.56Dec 22, 25$1.53Dec 24, 25$1.54Dec 29, 25$1.44Jan 2, 26$1.39Jan 6, 26$1.39Jan 8, 26$1.31Jan 12, 26$1.24Jan 14, 26$0.94Jan 16, 26$0.95Jan 21, 26$1.06Jan 23, 26$1.00Jan 27, 26$0.84Jan 29, 26$0.84Feb 2, 26$0.86Feb 4, 26$0.85Feb 9, 26$1.08Feb 11, 26$1.04Feb 13, 26$1.02Feb 18, 26$1.02Feb 20, 26$1.05Feb 24, 26$1.04Feb 26, 26$1.08Mar 2, 26$1.06Mar 4, 26$1.06Mar 6, 26$1.05Mar 10, 26$1.06Mar 12, 26$1.07Mar 17, 26$1.04Mar 19, 26$1.05Mar 23, 26$1.03Mar 25, 26$1.06Mar 27, 26$1.03Mar 31, 26$1.00Apr 2, 26$0.99Apr 7, 26$1.01Apr 9, 26$1.00Apr 13, 26$0.97Apr 15, 26$1.00Apr 17, 26$1.01Apr 22, 26$1.00Apr 24, 26$0.95Apr 28, 26$0.90Apr 30, 26$1.00May 4, 26$1.00May 6, 26$0.92May 8, 26$0.78May 12, 26$0.77May 14, 26$0.88May 18, 26$1.21May 20, 26$1.32May 22, 26$1.13May 28, 26$1.14Jun 1, 26$1.14Jun 3, 26$1.18Jun 5, 26$1.29Jun 9, 26$1.14Jun 11, 26$1.07Jun 15, 26$1.15Jun 17, 26$1.08Jun 22, 26$1.08Jun 24, 26$0.99Jun 26, 26$1.02Jul 2, 26$0.94
$0.7252-week range$2.69
Loading valuation history…

Fundamentals

Key fundamentals

$13.4M

Market cap

513.8%

Revenue growth (YoY)

-277.7%

Gross margin

-$4.4M

Free cash flow (USD)

-$1.6M

Net debt

Net cash position

0.9%

Share dilution

1/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2019 → 2025

FY 2019$0.00FY 2020$44.9KFY 2021$84.2KFY 2022$0.00FY 2023$290.6KFY 2024$52.0KFY 2025$319.2K
$0$319.2K

Free cash flow by year

2019 → 2025

FY 2019$-1.3MFY 2020$-828.4KFY 2021$-1.7MFY 2022$-1.4MFY 2023$-2.7MFY 2024$-3.0MFY 2025$-4.4M
-$1.3M-$4.4M

Gross margin by year

2021 → 2025

FY 202196.9%FY 2023131.4%FY 2024100.7%FY 2025-277.7%
96.9%-277.7%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

1

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last reported: Jun 30, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 6-K filingShare Purchase AgreementJun 23, 2026Filing
  • Insider buyInsider Buy $129KChoo Chee Kong · Director, 10% Owner · $128.8KJun 15, 2026Filing
  • Annual reportAnnual Report FiledJun 3, 2026Filing
  • 6-K filingManagement ChangeMay 15, 2026Filing
  • 6-K filingName Change AnnouncementMay 11, 2026Filing
  • Annual reportAnnual Report FiledApr 14, 2026Filing

Questions

Frequently asked questions

What is CytoMed Therapeutics Limited's market cap?

CytoMed Therapeutics Limited (GDTC) has a market capitalization of $13.4M.

What is GDTC's P/E ratio?

A meaningful P/E ratio is not available for GDTC — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

When did CytoMed Therapeutics Limited last report earnings?

GDTC last reported earnings on June 30, 2026; the next date is not yet scheduled.

Are insiders buying GDTC stock?

Yes — SEC Form 4 filings show 1 open-market insider buy and 0 sells at CytoMed Therapeutics Limited in the last 90 days.

Same arena

Related companies in Biotechnology

TRAW

Traws Pharma, Inc.

$13.4M

LPCN

Lipocine Inc.

$13.2M

CYCN

Cyclerion Therapeutics, Inc.

$13.6M

HIND

Vyome Holdings, Inc.

$13M

TAOX

TAO Synergies Inc.

$14M

PSTV

Plus Therapeutics, Inc.

$14.4M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.